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Abstract
We present activities undertaken in Poland’s Swietokrzyskie province to shorten the time to
recanalization of infarct-related arteries in patients with acute myocardial infarction. All emergency
medical institutions have been obliged by the Governor of Swietokrzyskie to implement the
System for Optimal Management of Acute Myocardial Infarction. The effects of this action are
discussed, and similar systems in Europe are reviewed. (Cardiol J 2011; 18, 2: 134–139)
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Introduction
Acute coronary syndromes (ACS) are a hetero-
geneous group of conditions with a sudden inter-
ruption of the blood flow in infarct-related arteries.
According to the guidelines of the European Socie-
ty of Cardiology (ESC), based on an ECG per-
formed on first medical contact (FMC) with the
patient, ACS are divided into ST segment elevation
ACS (STACS) and non-ST segment elevation ACS
(NSTACS) [1, 2]. Myocardial infarction (MI),
STEMI as well as NSTEMI, may develop in both
ACS categories and refers to irreversible cell inju-
ry within the myocardium supplied by the coronary
artery in which blood flow is impaired, usually due
to sudden and total occlusion. It is a life-threaten-
ing condition which, if left untreated, accounts for
about 40% of deaths in any one year and disability
among survivors. Until now, there has been no pre-
cise data on the incidence of ACS in Poland. It is
estimated that there are 80,000–100,000 patients
with ACS annually, of whom 30% have STEMI [3, 4].
In Swietokrzyskie province, with a population
of 1.25 million people, there are about 5,000 cases
of ACS annually, including 1,500 with STEMI [5].
The time from symptoms onset to the recana-
lization of the infarct-related artery has a tremen-
dous impact on the progression of myocardial ne-
crosis and consequently on in-hospital and late
mortality. Each additional 30 minute delay increas-
es annual mortality by about 7.5% [6].
An essential step in the management of
STEMI, according to the pathophysiology, research
and worldwide scientific guidelines, is achieving
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rapid and complete reperfusion. Reperfusion the-
rapy has been used since the 1980s, initially as in-
travenous fibrinolytic therapy, and now as primary
percutaneous coronary intervention (pPCI). This
technique was first applied in 1983 [7]. Now, after
30 years of refinement and the availability of a new
generation of balloon catheters, guidewires and
stents, novel diagnostic imaging and pharmacothe-
rapy, it has become a routine and effective strategy.
It can be applied in most patients with STEMI, it
permits achievement of complete reperfusion in 70–
–90% of patients, it reduces intracranial bleeding,
and, in patients with cardiogenic shock, it is the
method of choice. Primary PCI lowers significantly
mortality, nonfatal reinfarction and disabling stroke
rates.
According to the current ESC guidelines, pPCI
should be performed within 120 min after FMC. In
patients with extensive myocardial infarction (MI),
and those referred early (< 120 min from pain on-
set), this time should be lessened by 30 min. Only
if pPCI is not feasible within 120 min is fibrinolytic
therapy recommended [1].
Current evidence shows that the benefit of
early recanalization of the infarct-related artery is
unquestionable. Time from pain onset to myocar-
dial reperfusion determines prognosis (survival in
the acute phase, disability grade and ability to work).
In this clinical setting, each minute is important.
Primary PCI performed as early as possible after
the onset of pain is the best strategy to treat STEMI.
Treatment of acute coronary syndromes
in Swietokrzyskie province
The history of Swietokrzyskie cardiology and
the treatment of MI dates back to 1977 when the
first ward of cardiology was established in the Re-
gional Hospital of Kielce. Reperfusion therapy (fi-
brinolysis) in patients with STEMI was first used
in 1990. In 2000, the Swietokrzyskie Centre of Car-
diology (SCC) was opened, and first coronary an-
giography and angioplasty were performed in the
new cath lab opened in 2001. In 2002, a 24-hour on-
call duty schedule was introduced for the manage-
ment of patients with STEMI in the region. How-
ever, the maximum distance of 90–110 km to the
SCC, and consequently prolonged transport time,
prevented some patients from receiving invasive
therapy within the recommended timeframe. Ne-
vertheless, in 2005 and 2006 a 30-day mortality of
5.4% was noticed in STEMI patients who under-
went pPCI, which is comparable to the results ob-
tained in the best centers in the world [8]. Assum-
ing that pPCI has a tremendous effect on mortali-
ty, and that this method was to be available within
the recommended timeframe for the majority of
inhabitants of our region, we considered the wider
implementation of pPCI would further reduce mor-
tality and improve the quality of care. As a result,
new cath labs were opened to provide pPCI 24 hours
a day in Sandomierz in 2006, in Ostrowiec Swieto-
krzyski, Konskie and Starachowice in 2008 (Fig. 1).
According to the 2009 ESC project, it was re-
commended to perform pPCI in at least 70% of all
STEMI patients and to achieve pPCI rates of at least
600 per 1 million inhabitants per year [9]. In Swie-
tokrzyskie province, these recommendations re-
garding changes in rates were executed. In 2009,
pPCI was performed in 77.4% of STEMI patients
(880 patients per 1 million inhabitants) [5], which
is a better result than in most European countries.
However, the procedure was done outside the rec-
ommended timeframe in as many as 75% of STEMI
patients.
In Swietokrzyskie province, reports from the
heads of cardiac wards show that the longest de-
lays occur if STEMI patients are referred to a Hos-
pital Emergency Department (HED) and/or inten-
sive cardiac care unit (ICCU) without PCI capabili-
ties and only then transferred to a PCI-capable
hospital. This transportation pattern significantly
delays time to intervention and more radical mea-
sures should be undertaken to allow for transport
of patients directly to the nearest cath lab.
Under the National Emergency Medical Care
Act in Poland, patients with life-threatening medi-
cal emergencies must be transported without de-
lay to the nearest healthcare institution providing
specific treatment. In case of patients with MI, it
Figure 1. Cath labs in Swietokrzyskie province.
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should be the nearest invasive cardiology center
with a 24-hour duty schedule. A medical director
or emergency medical dispatcher (EMD) or physi-
cian medical co-ordinator decides where the patient
should be transferred. If the patient is going to be
sent to a hospital outside the EMD coverage area,
transport to the nearest invasive cardiology center
is co-ordinated by a physician medical co-ordinator.
In cases of referral to the HED (via the ambulance
service or self-referral) and the diagnosis of MI, the
responsibility for rapid transport rests with the re-
ferring hospital.
As it is evident that the longer the delay in
STEMI treatment, the greater the rates of morta-
lity, disability, therapy and other social costs, then
more radical measures should be undertaken to
change the situation [9–17]. Analysis of the data
from the Polish Registry of Acute Coronary Syn-
dromes (PL-ACS) [5] shows that in Swietokrzyskie
province in 2009, onset-to-balloon time exceeded
285 min and PCI centers door-to-balloon time was
73 min.
In these circumstances, it is advisable to ini-
tiate steps to reduce delay and to guarantee the
recommended timeframe, which should markedly
improve therapeutic outcome, reduce mortality rate
and disability grade in affected patients.
The Swietokrzyskie System
for Optimal Management of
Acute Myocardial Infarction
In order to reduce delay in seeking treatment
by patients with MI, co-ordinated activities had been
undertaken among potential patients, physicians
and emergency staff, ambulance service dispatch-
ers, hospital directors, doctors on the HEDs and
ICCUs and cath lab personnel (Table 1). The type
of activity was inspired by the initiatives underta-
ken in the framework of the Malopolska Registry of
Acute Coronary Syndromes as described elsewhere
[13, 14, 16, 17]. In order to implement these activi-
ties, as proposed by regional consultants in cardio-
logy and emergency medicine, Directors of the Swie-
tokrzyskie Center of Emergency Medicine, Dire-
ctors of the Ambulance Service and the National
Health Fund, the Governor of Swietokrzyskie prov-
ince passed a recommendation for establishing “The
Swietokrzyskie System for Optimal Treatment of
Acute Myocardial Infarction” [18] with the objec-
tives of:
1. Assure co-operation between ambulance servi-
ce and PCI-capable hospitals with a 24-hour
duty schedule, bypassing Hospital Emergency
Departments, to reduce time from pain onset
to reperfusion in patients with MI.
2. Use the optimal reperfusion strategy on car-
diological wards and in cath labs in compliance
with the guidelines.
3. Implement successful quality monitoring pro-
grammes in order to maintain permanent super-
vision over the organization of invasive therapy.
Analysis of similar solutions introduced in numer-
ous cardiological centers across Europe (Table 2)
shows that the monitoring of delay helped to iden-
tify the problem and the ensuing activities result-
ed in radical delay reduction, and consequently in-
creased the number of golden-hour patients, signi-
ficantly reduced in-hospital mortality and improved
markedly long-term prognosis in patients with
MI [9–16].
 Management strategies
in STEMI and NSTEMI
Different strategies are recommended depend-
ing on the initial diagnosis (STEACS or NSACS)
based on history, physical examination and ECG
Table 1. Activities undertaken to reduce delay in seeking treatment by patients with myocardial infarction.
To reduce Activities
Pain-to-diagnosis time Educational programs for patients and physicians in workplaces, schools,
and via press, radio and TV. Symptom knowledge determines intent to call
an ambulance.
Pre-hospital transport time Appropriate organization and co-operation of emergency service providers
— on-scene-to-arrival at hospital to assure immediate ambulance dispatch if myocardial infarction is suspected
and the swiftest transit to the invasive cardiology center.
In-hospital transport time Direct referral to the cardiac emergency department or cath lab, bypassing
— door-to-balloon time the Hospital Emergency Department and/or intensive cardiac care unit.
Patient monitoring from door to balloon to maintain staff motivation and
organizational efficacy. Mean time should not exceed 30 min!
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recording (Fig. 2) [1, 2, 13]. In all STEACS cases,
it is recommended to transport the patient imme-
diately and directly to the nearest PCI-capable hos-
pital with a 24 hours duty schedule in an ambulance
equipped with 12-lead ECG recorder and transmis-
sion system for interpretation by experienced staff
in a cath lab. All other ways of transport are dis-
couraged. If pPCI is not available within the recom-
mended timeframe, pharmacoinvasive therapy
should be considered. It concerns patients in whom
Table 2. Current experience — optimal care systems (data for 2003–2007) [7–9] and 2009 data for
Swietokrzyskie province [3]
Registry Pain-to-balloon time Transport time Cath lab door-to-balloon
[min]  [min]  time [min]
Prague-2 (the Czech Republic) 280 (90–470) 48 (28–68) 26 (15–37)
Danami-2 (Denmark)* 224 (171–317) 32 (20–45) 26 (20–38)
Vienna Registry (Austria) 258 (90–426) 20 31 (8–54)
RIKS-HIA (Sweden) 210 (135–334) 39 (22–65) 30 (12–70)
PL-ACS (Swietokrzyskie province) 285 (150–590) 52 (37–79) 73 (50–166)
*Median and quartile range, all other values are mean ± SD
Figure 2. Strategy outline for acute coronary syndrome (ACS) patients according to the “Swietokrzyskie System for
Optimal Management of Myocardial Infarction” (modified from [10]).
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PCI is not feasible < 2 h from pain onset and
< 90 min in case of patients with high risk MI.
A pharmacoinvasive strategy consists of pre-hos-
pital fibrinolysis and then transfer to a PCI center
for coronary angiography within the first 24 h after
effective fibrinolysis and within six hours after in-
effective thrombolytic therapy (Fig. 3).
Patients with NSTEMI should be referred to
the nearest Hospital Emergency Department or
admissions office of the community hospital for ini-
tial risk assessment. High-risk patients should be
transferred directly to the nearest invasive cardi-
ology center within 72 h (ideally < 24 h). Only low-
risk patients should be admitted to cardiac and in-
ternal medicine wards in hospitals without 24 h duty
schedules to decide about further management, in-
cluding invasive diagnostic procedures to identify
coronary artery disease.
To assure the successful implementation of
the above described system requires the in-
volvement of both governmental bodies and
healthcare workers.  So, the following changes in
transport system and patient management have
been made:
1. Optimization of transportation as required, with
particular emphasis on direct transport of pa-
tients with definite STEMI to an interventio-
nal cardiology center, bypassing HEDs and/or
ICCUs.
2. Implementation of ECG teletransmission (from
an ambulance and emergency departments in
smaller hospitals to the nearest interventional
cardiology center) in cases when the diagno-
sis of STEMI based on the ECG recording is
equivocal and requires destination decision.
3. Continuous education for healthcare workers
(rescuers, ambulance, admissions and emer-
gency department physicians) on the manage-
ment of STEMI.
4. Permanent monitoring of the whole system in
order to eliminate weak points and improve the
quality of care for STEMI patients.
Conclusions
Introducing a pPCI service in Swietokrzyskie
province resulted in a decrease of mortality in inva-
sively treated STEMI patients of 5.4%. A further im-
provement is expected after optimization of transpor-
tation for STEMI patients and implementation of “The
Swietokrzyskie System for Optimal Management of
Acute Myocardial Infarction”. The practice of direct
ambulance transfer to cath labs will reduce delay from
diagnosis to intervention, and consequently improve
treatment outcomes. Results of the programme will
be evaluated via permanent monitoring of delay from
diagnosis to intervention and 30-day mortality (quali-
ty monitoring in invasive treatment of MI).
Figure 3. Optimal STEMI treatment strategy.
139
Janusz Sielski et al., The Swietokrzyskie System for the Optimal Management of Acute Myocardial Infarction
www.cardiologyjournal.org
Acknowledgements
The authors do not report any conflict of inte-
rest regarding this work.
References
1. Van de Werf F, Bax J, Betriu A et al. Management of acute
myocardial infarction in patients presenting with persistent
ST-segment elevation: The Task Force on the Management
of ST-Segment Elevation Acute Myocardial Infarction of the
European Society of Cardiology. Eur Heart J, 2008; 29: 2909–
–2945.
2. Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the
diagnosis and treatment of non ST-segment elevation acute co-
ronary syndromes. Eur Heart J, 2007; 28: 1598–1660.
3. Poloński L, Gąsior M, Gierlotka M et al. Polish Registry of Acute
Coronary Syndromes (PL-ACS). Characteristics, treatments and
outcomes of patients with acute coronary syndromes in Poland.
Kardiol Pol, 2007; 65: 861–872.
4. Hasdai D, Behar S, Wallentin L et al. A prospective survey of
the characteristics, treatments and outcomes of patients with
acute coronary syndromes in Europe and the Mediterranean
basin; the Euro Heart Survey of Acute Coronary Syndromes
(Euro Heart Survey ACS). Eur Heart J, 2002; 23: 1190–1201.
5. Janion M. Sprawozdanie Konsultanta Wojewódzkiego w dzie-
dzinie Kardiologii za rok 2009.
6. De Luca G, Suryapranata H, Ottervanger JP, Antman EN. Time
delay to treatment and mortality in primary angioplasty for acute
myocardial infarction: every minute of delay counts. Circulation,
2004; 109: 1223–1225.
7. Hartzler GO, Rutherford BD, McConahay DR et al. Percutaneous
transluminal coronary angioplasty with and without thrombolytic
therapy for treatment of acute myocardial infarction. Am Heart J,
1983; 106: 965–973.
8. Janion M, Polewczyk A, Gąsior M, Poloński L. Progress in the
management of ST-segment elevation myocardial infarction dur-
ing economic transition in Poland between 1992 and 2006. Int
J Cardiol, 2009; 135: 253–265.
9. Widimsky P, Fajadet J, Danchin N, Wijns W. “Stent 4 Life” targe-
ting PCI at all who will benefit the most. A joint project between
EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on
Acute Cardiac Care. EuroInterventio, 2009; 4: 555–557.
10. Knot J, Widimsky P, Wijns W et al. How to set up an effective
national primary angioplasty network: Lessons learned from five
European countries. EuroIntervention, 2009; 5: 299–309.
11. Widimsky P, Zelisko M, Jansky P et al. The incidence, treatment
strategies and outcomes of acute coronary syndromes in the
“reperfusion network” of different hospital types in the Czech
Republic: Results of the Czech evaluation of acute coronary syn-
dromes in hospitalized patients (CZECH) registry. Int J Cardiol,
2007; 119: 212–219.
12. Kalla K, Christ G, Karnik R et al. Implementation of guidelines
improves the standard of care: the Vienna registry on reperfu-
sion strategies in ST-elevation myocardial infarction (Vienna
STEMI registry). Circulation, 2006; 113: 2398–2405.
13. Dudek D, Legutko J, Siudak Z et al. Organizacja interwencyj-
nego leczenia pacjentów z zawałem serca STEMI i NSTEMI
w Polsce. Kardiol Pol, 2010; 68: 618–624.
14. Dudek D, Siudak Z, Dziewierz A et al. Local hospital networks
for STEMI treatment for a population of half a million inhabit-
ants increase the use of invasive treatment of acute coronary
syndromes to the European recommended level. The Mało-
polska Registry of Acute Coronary Syndromes 2005–2006. Kar-
diol Pol, 2008; 66: 489–497.
15. Polewczyk A, Janion M, Gąsior M, Gierlotka M. Myocardial in-
farction in the elderly. Clinical and therapeutic differences.
Kardiol Pol, 2008; 66: 166–172.
16. Dudek D, Rakowski T, Dziewierz A, Mielecki W. Time delay in
primary angioplasty: how relevant is it? Heart, 2007; 93: 1164–
–1166.
17. Dudek D, Rakowski T, El Massri N et al. Patency of infarct
related artery after pharmacological reperfusion during transfer
to primary percutaneous coronary intervention influences left
ventricular function and one-year clinical outcome. Int J Cardiol,
2008; 124: 26–31.
18. Pałka-Koruba B. Governor of Swietokrzyskie Province “The
Swietokrzyskie System for Optimal Treatment of Myocardial
Infarction”. Polish CZP. IV.0717-19/10, Kielce, 21.04.2010.
